NuScale underwent significant capital restructuring with stockholders' equity roughly doubling alongside a substantial decline in gross profit margins.
The dramatic increase in stockholders' equity suggests either a major capital raise or corporate restructuring that has strengthened the balance sheet. However, the company's operational performance deteriorated meaningfully, with gross profit declining substantially while revenue fell more modestly, indicating compressed margins and potential execution challenges.
NuScale's financial profile shifted dramatically in fiscal 2026, with stockholders' equity roughly doubling to $1.2 billion, likely reflecting significant capital infusion or restructuring activities. However, operational metrics moved in the opposite direction, as revenue declined 15% to $31.5 million while gross profit fell substantially to $11.4 million, compressing gross margins from roughly 87% to 36%. The divergence between strengthened capital position and weakening operational performance suggests the company is in a capital-intensive development phase with near-term profitability challenges.
Equity base grew 88.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Revenue softened 15% — monitor whether this is cyclical or structural.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →